Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3492
Gene Symbol: IGH
IGH
0.070 GeneticVariation phenotype BEFREE Partial versus productive immunoglobulin heavy locus rearrangements in chronic lymphocytic leukemia: implications for B-cell receptor stereotypy. 21968789 2012
Entrez Id: 3492
Gene Symbol: IGH
IGH
0.070 GeneticVariation phenotype BEFREE To test the hypothesis that signaling through innate immunity receptors may influence the behavior of the malignant clone, we investigated the functional response triggered by the stimulation of TLRs and NOD2 in 67 CLL cases assigned to different subgroups on the basis of immunoglobulin heavy variable (IGHV ) gene usage, IGHV gene mutational status or B-cell receptor (BcR) stereotypy. 22437326 2012
Entrez Id: 3492
Gene Symbol: IGH
IGH
0.070 Biomarker phenotype BEFREE IGHV1-69/51p1 is expressed by ∼ 30% of unmutated chronic lymphocytic leukemia (U-CLL) and combines with selected IGHD and IGHJ genes generating stereotypes if HCDR3 amino acid homology is > 60%. 22234701 2012
Entrez Id: 3492
Gene Symbol: IGH
IGH
0.070 Biomarker phenotype BEFREE LC- and HC-MBL had similar somatic hypermutation status, yet different IGHV gene repertoires and frequencies of B-cell receptor (BcR) stereotypy. 23596047 2013
Entrez Id: 3492
Gene Symbol: IGH
IGH
0.070 Biomarker phenotype BEFREE In chronic lymphocytic leukemia (CLL), the geographical bias in immunoglobulin heavy-chain variable (IGHV) gene usage lead us to analyze IGHV gene usage and B-cell receptor stereotypy in 195 patients from India. 26942309 2016
Entrez Id: 3492
Gene Symbol: IGH
IGH
0.070 Biomarker phenotype BEFREE All spontaneously regressed tumors were IGHV-mutated with no restricted IGHV usage or B-cell receptor (BCR) stereotypy. 31794600 2020
Entrez Id: 3492
Gene Symbol: IGH
IGH
0.070 GeneticVariation phenotype BEFREE We studied the antigen-binding characteristics of 23 CLL-derived, recombinantly-expressed IGs with 5 pathogenic bacteria, determining that CLL IGs differ in bacterial reactivity based on IGHV gene use, mutation status, and association with IGHD and IGHJ genes ("stereotypy"). 27586592 2016
Entrez Id: 102724971
Gene Symbol: LOC102724971
LOC102724971
0.040 Biomarker phenotype BEFREE Immunoglobulin heavy chain variable region gene repertoire and B-cell receptor stereotypes in Indian patients with chronic lymphocytic leukemia. 26942309 2016
Entrez Id: 28402
Gene Symbol: IGHV3-69-1
IGHV3-69-1
0.040 Biomarker phenotype BEFREE LC- and HC-MBL had similar somatic hypermutation status, yet different IGHV gene repertoires and frequencies of B-cell receptor (BcR) stereotypy. 23596047 2013
Entrez Id: 28309
Gene Symbol: IGHV3OR16-7
IGHV3OR16-7
0.040 Biomarker phenotype BEFREE LC- and HC-MBL had similar somatic hypermutation status, yet different IGHV gene repertoires and frequencies of B-cell receptor (BcR) stereotypy. 23596047 2013
Entrez Id: 28402
Gene Symbol: IGHV3-69-1
IGHV3-69-1
0.040 Biomarker phenotype BEFREE All spontaneously regressed tumors were IGHV-mutated with no restricted IGHV usage or B-cell receptor (BCR) stereotypy. 31794600 2020
Entrez Id: 28402
Gene Symbol: IGHV3-69-1
IGHV3-69-1
0.040 GeneticVariation phenotype BEFREE To test the hypothesis that signaling through innate immunity receptors may influence the behavior of the malignant clone, we investigated the functional response triggered by the stimulation of TLRs and NOD2 in 67 CLL cases assigned to different subgroups on the basis of immunoglobulin heavy variable (IGHV ) gene usage, IGHV gene mutational status or B-cell receptor (BcR) stereotypy. 22437326 2012
Entrez Id: 28309
Gene Symbol: IGHV3OR16-7
IGHV3OR16-7
0.040 Biomarker phenotype BEFREE All spontaneously regressed tumors were IGHV-mutated with no restricted IGHV usage or B-cell receptor (BCR) stereotypy. 31794600 2020
Entrez Id: 102723407
Gene Symbol: LOC102723407
LOC102723407
0.040 Biomarker phenotype BEFREE Immunoglobulin heavy chain variable region gene repertoire and B-cell receptor stereotypes in Indian patients with chronic lymphocytic leukemia. 26942309 2016
Entrez Id: 102724971
Gene Symbol: LOC102724971
LOC102724971
0.040 Biomarker phenotype BEFREE LC- and HC-MBL had similar somatic hypermutation status, yet different IGHV gene repertoires and frequencies of B-cell receptor (BcR) stereotypy. 23596047 2013
Entrez Id: 102723407
Gene Symbol: LOC102723407
LOC102723407
0.040 GeneticVariation phenotype BEFREE To test the hypothesis that signaling through innate immunity receptors may influence the behavior of the malignant clone, we investigated the functional response triggered by the stimulation of TLRs and NOD2 in 67 CLL cases assigned to different subgroups on the basis of immunoglobulin heavy variable (IGHV ) gene usage, IGHV gene mutational status or B-cell receptor (BcR) stereotypy. 22437326 2012
Entrez Id: 102723407
Gene Symbol: LOC102723407
LOC102723407
0.040 Biomarker phenotype BEFREE LC- and HC-MBL had similar somatic hypermutation status, yet different IGHV gene repertoires and frequencies of B-cell receptor (BcR) stereotypy. 23596047 2013
Entrez Id: 102723407
Gene Symbol: LOC102723407
LOC102723407
0.040 Biomarker phenotype BEFREE All spontaneously regressed tumors were IGHV-mutated with no restricted IGHV usage or B-cell receptor (BCR) stereotypy. 31794600 2020
Entrez Id: 28402
Gene Symbol: IGHV3-69-1
IGHV3-69-1
0.040 Biomarker phenotype BEFREE Immunoglobulin heavy chain variable region gene repertoire and B-cell receptor stereotypes in Indian patients with chronic lymphocytic leukemia. 26942309 2016
Entrez Id: 28309
Gene Symbol: IGHV3OR16-7
IGHV3OR16-7
0.040 GeneticVariation phenotype BEFREE To test the hypothesis that signaling through innate immunity receptors may influence the behavior of the malignant clone, we investigated the functional response triggered by the stimulation of TLRs and NOD2 in 67 CLL cases assigned to different subgroups on the basis of immunoglobulin heavy variable (IGHV ) gene usage, IGHV gene mutational status or B-cell receptor (BcR) stereotypy. 22437326 2012
Entrez Id: 102724971
Gene Symbol: LOC102724971
LOC102724971
0.040 Biomarker phenotype BEFREE All spontaneously regressed tumors were IGHV-mutated with no restricted IGHV usage or B-cell receptor (BCR) stereotypy. 31794600 2020
Entrez Id: 102724971
Gene Symbol: LOC102724971
LOC102724971
0.040 GeneticVariation phenotype BEFREE To test the hypothesis that signaling through innate immunity receptors may influence the behavior of the malignant clone, we investigated the functional response triggered by the stimulation of TLRs and NOD2 in 67 CLL cases assigned to different subgroups on the basis of immunoglobulin heavy variable (IGHV ) gene usage, IGHV gene mutational status or B-cell receptor (BcR) stereotypy. 22437326 2012
Entrez Id: 28309
Gene Symbol: IGHV3OR16-7
IGHV3OR16-7
0.040 Biomarker phenotype BEFREE Immunoglobulin heavy chain variable region gene repertoire and B-cell receptor stereotypes in Indian patients with chronic lymphocytic leukemia. 26942309 2016
Entrez Id: 6505
Gene Symbol: SLC1A1
SLC1A1
0.020 AlteredExpression phenotype BEFREE Conversely, activation of intracellular signaling pathways coupled to mGluRI in D1R-containing striatal neurons of mice expressing EAAC1 leads to reduced D1R protein level and increased stereotyped movement execution. 29229708 2018
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.020 Biomarker phenotype BEFREE The present study aimed at revealing the role of the DAT in the individual brain response stereotypy underlying cognitive flexibility. 20141527 2010